ADIPOQ and heart failure: The second hypothesis, supported by animal models, introduces the concept of adiponectin resistance—studies in humans, such as those by Van Berendoncks et al. (2010), have shown that despite increased adiponectin expression in skeletal muscle, heart failure patients exhibit down‐regulated adiponectin receptors, suggesting functional adiponectin resistance (Engin, 2024).